Success Metrics

Clinical Success Rate
97.2%

Based on 35 completed trials

Completion Rate
97%(35/36)
Active Trials
4(10%)
Results Posted
20%(7 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_1
4
10%
Ph phase_3
12
29%
Ph phase_4
19
45%
Ph not_applicable
1
2%
Ph phase_2
4
10%

Phase Distribution

4

Early Stage

4

Mid Stage

31

Late Stage

Phase Distribution40 total trials
Phase 1Safety & dosage
4(10.0%)
Phase 2Efficacy & side effects
4(10.0%)
Phase 3Large-scale testing
12(30.0%)
Phase 4Post-market surveillance
19(47.5%)
N/ANon-phased studies
1(2.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

97.2%

35 of 36 finished

Non-Completion Rate

2.8%

1 ended early

Currently Active

4

trials recruiting

Total Trials

42

all time

Status Distribution
Active(5)
Completed(35)
Terminated(1)
Other(1)

Detailed Status

Completed35
Recruiting3
Active, not recruiting1
Terminated1
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
42
Active
4
Success Rate
97.2%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (10.0%)
Phase 24 (10.0%)
Phase 312 (30.0%)
Phase 419 (47.5%)
N/A1 (2.5%)

Trials by Status

completed3583%
recruiting37%
active_not_recruiting12%
terminated12%
unknown12%
not_yet_recruiting12%

Recent Activity

Clinical Trials (42)

Showing 20 of 42 trialsScroll for more
NCT07566351Phase 2

Effect of Roflumilast and Desloratadine as Add-On Therapy in Patients With Rheumatoid Arthritis

Recruiting
NCT07486583Phase 3

Autologous Whole Blood Therapy in Chronic Idiopathic Urticaria Patients.

Not Yet Recruiting
NCT07333716Phase 2

Desloratadine in Patients With Ulcerative Colitis

Recruiting
NCT05214911Phase 3

Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in Children

Completed
NCT06916884Phase 3

Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine

Recruiting
NCT00751218Phase 4

A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)

Completed
NCT00789152Phase 3

The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609)

Completed
NCT00311844Phase 4

A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)

Completed
NCT00757562Phase 3

Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994)

Completed
NCT00783354Phase 4

A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)

Completed
NCT00779636Phase 4

Effectiveness and Safety of Desloratadine in Patients With Allergic Airway Disease During the Pollen Season (Study P03284)

Completed
NCT00751166Phase 4

A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)

Terminated
NCT00867191Phase 4

Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836)

Completed
NCT00783146Phase 4

Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)

Completed
NCT00783211Phase 4

Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED)

Completed
NCT01916967Phase 3

An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)

Completed
NCT06268470Phase 2

Antiplatelet Therapy in Chronic Urticaria

Active Not Recruiting
NCT05446480Not Applicable

Role of Desloratadine in Reducing Inflammation From Occupational Heat Strain

Unknown
NCT00805584Phase 4

Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442)

Completed
NCT00795158Phase 3

How Desloratadine (Clarinex, Aerius) Affects Quality of Life in Patients With Chronic Idiopathic Urticaria (Have Had Hives for 6 Weeks or Longer)(Study P02988)

Completed

Drug Details

Intervention Type
DRUG
Total Trials
42